These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20179959)

  • 21. Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1787-9. PubMed ID: 18795314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration.
    Levy J; Shneck M; Rosen S; Klemperer I; Rand D; Weinstein O; Pitchkhadze A; Belfair N; Lifshitz T
    Int Ophthalmol; 2009 Oct; 29(5):349-57. PubMed ID: 18545937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.
    Saati S; Agrawal RN; Louie S; Chader GJ; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):457-66. PubMed ID: 19644699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
    Arevalo JF; Wu L; Sanchez JG; Maia M; Saravia MJ; Fernandez CF; Evans T
    Eye (Lond); 2009 Jan; 23(1):117-23. PubMed ID: 17891058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin).
    Isaacs TW; Barry C
    Clin Exp Ophthalmol; 2006 Nov; 34(8):802-3. PubMed ID: 17073910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravitreal bevacizumab in neovascularisation secondary to age-related macular degeneration].
    Ordóñez Fernández L; Celemín Viñuela ML; Fernández Lisa C; García Alonso A; Fonolla Gil M; Fernández Bustillo E
    Farm Hosp; 2008; 32(1):53-4. PubMed ID: 18426702
    [No Abstract]   [Full Text] [Related]  

  • 27. LSFG findings of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
    Enaida H; Okamoto K; Fujii H; Ishibashi T
    Ophthalmic Surg Lasers Imaging; 2010 Dec; 41 Online():e1-3. PubMed ID: 21117574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
    Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
    Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
    Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
    Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.
    Honda S; Hirabayashi H; Tsukahara Y; Negi A
    Graefes Arch Clin Exp Ophthalmol; 2008 Jul; 246(7):1061-3. PubMed ID: 18320201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
    Kusaka S; Shima C; Wada K; Arahori H; Shimojyo H; Sato T; Fujikado T
    Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy.
    Zhang Q; Zhang J; Guan Y; Zhang S; Zhu C; Xu GT; Wang L
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):919-27. PubMed ID: 19301028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intravitreal bevacizumab in the management of Eales' disease.
    Chanana B; Azad RV; Patwardhan S
    Int Ophthalmol; 2010 Feb; 30(1):57-61. PubMed ID: 19165424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema.
    Shetty R; Pai SA; Vincent A; Shetty N; Narayana KM; Sinha B; Shetty BK
    Doc Ophthalmol; 2008 Mar; 116(2):129-35. PubMed ID: 17960440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.
    Spaide RF; Fisher YL
    Retina; 2006 Mar; 26(3):275-8. PubMed ID: 16508426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy.
    Shaikh S
    Indian J Ophthalmol; 2008; 56(3):259. PubMed ID: 18417840
    [No Abstract]   [Full Text] [Related]  

  • 37. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
    Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
    Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
    [No Abstract]   [Full Text] [Related]  

  • 40. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).
    Rizzo S; Genovesi-Ebert F; Di Bartolo E; Vento A; Miniaci S; Williams G
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):837-42. PubMed ID: 18286296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.